Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Direxion Daily Semiconductor Bear 3X Shares (SOXS) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Direxion Daily Semiconductor Bear 3X SharesTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Direxion Daily Semiconductor Bear 3X Shares vs Health Care Select Sector SPDR Fund — how do they compare? Direxion Daily Semiconductor Bear 3X Shares trades at $34.39 (market cap $1.96B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 22.2× Direxion Daily Semiconductor Bear 3X Shares's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Direxion Daily Semiconductor Bear 3X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily Semiconductor Bear 3X Shares for 11 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

SOXSXLV
Market Cap
$1.96B$43.48B
Volume
113,512,54111,121,431
Sector
Leveraged / Inverse—
52-Week High
$988.00$175.68
52-Week Low
$29.62$141.95
Typical Hold Time
11 Days100 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Direxion Daily Semiconductor Bear 3X Shares

SOXS, the Direxion Daily Semiconductor Bear 3X ETF, surged 10.23% to $33.78 amid semiconductor sector volatility. The technical outlook remains bearish with moving averages signaling continued downward pressure, while oscillators show neutral momentum. Recent news highlights SOXS benefiting from semiconductor sell-offs, though analysts caution it's suited only for short-term tactical trades due to extreme volatility and structural decay inherent in leveraged inverse ETFs.

As a leveraged inverse ETF, SOXS carries significant risks including daily rebalancing costs and time decay, making it unsuitable for long-term holdings. The fund thrives during semiconductor downturns but faces headwinds from persistent AI hardware demand. Investors should recognize this as a speculative trading instrument rather than a fundamental investment vehicle.

Health Care Select Sector SPDR Fund

XLV trades at $168.16, down 0.39% with a bearish technical signal from moving averages. The healthcare ETF maintains strong cost advantages with a 0.08% expense ratio compared to peers. Recent news highlights XLV's defensive positioning during market volatility and its historical outperformance during Fed rate hikes. Technical indicators show RSI levels in neutral territory while ADX signals selling pressure.

XLV offers diversified healthcare exposure with competitive expense ratios, positioning it well for defensive investing. Key risks include political uncertainty around healthcare policy and concentrated exposure to domestic S&P 500 stocks. The ETF's low-cost structure and sector diversification provide stability amid market volatility, though technical indicators suggest near-term caution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SOXS
27% Buy73% Sell
Avg holding period · 11 Days
XLV
44% Buy56% Sell
Avg holding period · 100 Days

About Direxion Daily Semiconductor Bear 3X Shares

SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.

Read more on SOXS →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →